Pharmaceutical Contract Manufacturing. Technology Transfer

This section is devoted to the Contract Manufacturing of Pharmaceuticals at the facilities of independent producers, who are fully compliant with technological processes and Quality Control in accordance with client requirements

Types of Contractors

  • Manufacturers, who specialize only in Contract Manufacturing
  • Manufacturers, who produce their own brands along with Contract Manufacturing

Types of Contract Services

  • Full-cycle manufacturing
  • Performing only some of the manufacturing operations (ex. packaging)
drug development

Moscow plans to further develop offset agreement mechanism

Offset agreements are a new effective mechanism for public procurement, in which the supplier agrees to establish or upgrade a production facility within the city, while the city authorities agree to purchase the products.

3P Biopharmaceuticals signed a contract manufacturing agreement with Intervacc

3P Biopharmaceuticals, a Spanish biotechnology company, and the Swedish company Intervacc completed negotiations and signed the agreement for contract manufacturing of Strangvac®.

Milan hosted a convention of the Russian-Italian subgroup for pharma industry

A delegation of the Russian Ministry of Industry and Trade lead by the Head of the Department of Pharmaceutical and Medical Industry Development – arrived in Italy with a mission to support cooperation between the countries.

Rentschler Biopharma and Leukocare reported about effective cooperation

Rentschler Biopharma SE, a leading contract development and manufacturing organization, and Leukocare AG, a biotechnology company, reported on the successful first year of their unique strategic alliance.

Takeda Russia launches a combined sugar-lowering drug

Takeda, a pharmaceutical company, has developed an innovative sugar-lowering drug that is a combination of alogliptin and metformin. The representatives of the company announced that the drug was launched in the Russian market.

MSD and AKRIKHIN localized manufacturing of sitagliptin in Russia

MSD, an innovative global pharmaceutical company, and AKRIKHIN, a leading Russian pharmaceutical manufacturer, announced the successful localization of 100 mg finished dosage form of sitagliptin.

Janssen intends to manufacture bedaquiline at the Pharmstandard plant in Ufa

Janssen Pharmaceutica N.V., a part of Janssen Pharmaceutical Companies of Johnson & Johnson, signed a memorandum of intent with Pharmstandard JSC to manufacture and supply Sirturo®, a medicinal product.
fas russia

SPICs should involve the transfer of unique technologies

“Special Investment Contract cannot provide guarantees for the implementation of unfair activities,” said Timofey Nizhegorodtsev, the Head of the Department for Control over Social Sphere and Trade of FAS of Russia.
samsung biologics

Samsung Biologics signed the first contract for its newly built Plant 3

Samsung BioLogics entered into the first manufacturing contract for its Plant 3 facility. The approximate value of the contract is $148 million if the product will be successful in the clinic.

Contact Manufacturing Companies